The last five Ebola patients have been discharged from a treatment centre in the Democratic Republic of Congo, marking a critical milestone in the fight against the deadly virus. UK medical teams played a vital role in the response, according to sources on the ground. The outbreak, which began in August 2018, has claimed over 2,200 lives.
But today, the news is different. The medical personnel who risked their lives in the war-torn region are being hailed as heroes. Yet beneath the headlines, questions linger about the funding and logistics that made this possible.
The UK's contribution, including a £50 million package, has been praised. But who really benefits from this victory? The pharmaceutical industry?
The government's image? Let's not forget the bodies that were buried in unmarked graves, the families torn apart. This is not a clean story.
The virus may be contained, but the systemic failures that allowed it to spread remain. The money trail leads to contracts awarded to companies with ties to government officials. Are we celebrating a victory or a cover-up?
The health minister's statement yesterday was polished, but the documents I've seen tell a different tale. The UK's involvement was not purely altruistic. There are patents, profits, and power plays at work.
For now, five people walk free. But the real story is just beginning.
